Morrison & Foerster Partner Catherine Polizzi will speak at PMWC 2013. She will give a personalized medicine patent law update focusing on how patent law continues to evolve in ways that significantly impact personalized medicine companies. This talk will provide a concise synopsis of recent cases decided by the Federal Circuit and Supreme Court, and their impact on patent strategies available for protecting personalized medicine inventions. Catherine’s presentation will focus on a set of decided cases focused on the patent eligibility of diagnostic method claims. A follow-up presentation will go on to cover the Myriad case, now at the Supreme Court, and its impact on personalized medicine companies. Both talks will highlight thematic elements of the case law and provide context for personalized medicine executives seeking to understanding their implications for developing effective patent strategies.